
Taking The Supply Chain Pulse · 2026-06-18 · 30 min
Key moments - from our scoring
Substance score
43 / 100
Five dimensions, 20 points each
Healthcare supply chains represent roughly 40% of health system operating budgets, yet remain significantly underinvested in technology compared to capital assets and logistics infrastructure. Eric O'Daffer makes a compelling case for rebalancing these investments toward integrated AI platforms that can consolidate data across 30-60 different supply chain touchpoints. Rather than fragmented point solutions, O'Daffer advocates for health systems to select platform vendors aligned with their AI strategy - including companies like Clarion (AI platform), Logic Source (indirect spend management), and Visiant (benchmarking and maturity assessment). Mature health systems including Mayo Clinic, Cleveland Clinic, Intermountain, Stanford, and Advent Health have demonstrated real ROI in areas like preference card standardization, transactional pricing optimization, and supply chain resiliency. O'Daffer notes the industry is in "inning two of a nine-inning game" with AI adoption, meaning early outcomes show promise but infrastructure and talent gaps remain. His advisory work focuses on helping health systems shift budget from legacy ERP investments and episodic platforms toward next-generation solutions that reduce manual labor through agents while improving decision-making through better data utilization.
Indirect spend accounts for approximately 40% of total health system supply chain costs (products and services not delivered in boxes across 800+ categories), yet it has received minimal technology investment and progress compared to direct medical-surgical products, making it a major opportunity for AI-driven optimization.
Mayo Clinic, Cleveland Clinic, Intermountain, Stanford, and Advent Health have made significant investments in AI as core business operations, demonstrating success in areas like preference card management, pricing optimization, and supply chain resiliency.
O'Daffer recommends selecting a single integrated platform vendor with a roadmap aligned to the organization's broader AI strategy rather than implementing 10-20 different point solutions, which creates complexity and fragmentation.
Clear ROI is demonstrable in preference card standardization, transactional pricing verification, spend rationalization to ensure consistent pricing, and improved compliance with contract terms; resiliency and supply chain predictability deliver softer dollar value.
Most health systems view technology adoption as an opportunity (eager rather than desperate), though many struggle to identify where to start and face pressure from staffing shortages that make labor-reduction through AI agents attractive.
Our reviewer’s read on each dimension, with quotes from the episode.
The episode contains a handful of useful benchmark figures (40% of health system supply chain tied to indirect/services spend, 800 categories, capital equipment at 7% of total supply chain spend) but the bulk of the conversation is high-level advisory framing - 'lean into platforms,' 'get governance,' 'be an early adopter' - with little tactical depth or mechanisms a practitioner could act on immediately.
40% of the total cost of supply chain if the health system is related to products that don't come and of services that don't come in a box. Um, you know, 800 different categories of them.
Today we see it managed still predominantly on spreadsheets
The episode recycles familiar advisory thinking - early adopters win, governance is required, platform beats point solutions - without offering contrarian or first-principles arguments. The only mildly fresh observation is capital equipment's cybersecurity dimension being pushed to the CTO, but even that is underdeveloped.
my my take is it's better for most folks to be an early adopter um, you know, and and and be part of the solution and and building it out
it is platform with an expectation that you're gonna go down the roadmap
O'Daffer brings genuine credibility as former head of healthcare at Gartner with decades of research in the space, and he can name specific health systems and spend categories from experience. However, he is now operating in an advisory/advocacy capacity for the very vendors he promotes, which clouds his perspective and moves him toward thought-leader rather than active operator.
you can you can look to some of the more mature health systems uh in my old world at Gartner, uh the Mayo Clinics, the Cleveland Clinics, uh Intermountain, um, Stanford, uh, Advent Health
I'm an advisor for Logic Source
There are some concrete anchor figures (40% indirect spend, 800 categories, 70% of MedSurge for capital equipment, 7-10% of total supply chain spend, $3-5B health systems with only two people managing capital) but ROI claims are vague ('some pretty clear ROI'), no customer case studies with named outcomes, and all vendor references double as plugs for clients.
the number of health systems that I talk to that are you know three to five billion dollars that have a couple people kind of randomly doing capital equipment
it's not quite the equivalent of MedSurge in terms of dollars, but it's 70% of it
The host frequently answers his own questions before the guest can and relies heavily on 'Is that fair to say?' as a closing move, which invites confirmation rather than depth. Significant time is spent on Seattle weather and a tangential military budget anecdote, and no claim by the guest is meaningfully challenged or probed for specifics.
You know, how come the defense budget is shot up to the point where it's nine hundred and seventy billion dollars now?
Is that fair to say?
Computed from the transcript - who did the talking, and the words that came up most.
Transcribed and scored by The B2B Podcast Index.
1 - > SPEAKER_00: Welcome back to another episode of Taking the 2 - > Supply Chain Pulse. 3 - > I'm Joe Nemeth with St. 4 - > Orange Company, and today we're joined by Eric O'Daffer, 5 - > Managing Director of Healthcare Advisory LLC and former head of 6 - > healthcare at Gartner. 7 - > Eric brings decades of experience at the intersection 8 - > of strategy, innovation, and healthcare leadership.
9 - > So let's dive in with your host, Fred Crantons. 10 - > Take it away, Freddie. 11 - > SPEAKER_03: So, Eric, uh welcome. 12 - > Happy to have you on.
13 - > SPEAKER_02: It's great to be here, Fred. 14 - > Looking forward to it. 15 - > SPEAKER_03: You're out there in Seattle, right? 16 - > Is it raining?
17 - > SPEAKER_02: It is going to rain. 18 - > Uh, you know, just drips. 19 - > Uh this is the time of year we call January here. 20 - > Uh the rest of the country gets summer, and we get uh, you know, 21 - > 55 and rainy for the first couple weeks of June, but then 22 - > it turns beautiful and is uh you know the greatest place on 23 - > earth.
24 - > But uh the June, early June, not uh not our best foot forward. 25 - > SPEAKER_03: It is a great place. 26 - > I I love it out there. 27 - > So what tell us, Eric, um what have you been doing since you 28 - > left Gartner?
29 - > You you left what a couple years ago or a little over a year ago? 30 - > What have you been doing? 31 - > SPEAKER_02: Yeah, well, it uh you're you're right. 32 - > It's been just a little over a year, uh I think April of uh 33 - > 2025, and um you know I intended to retire um and uh kind of done 34 - > what I could do at at Gartner, I felt that it had run its course 35 - > for me.
36 - > Um still believe in in what they're doing over there, but uh 37 - > for me it was it was time to to be done. 38 - > And then uh a few companies reached out as I did that and 39 - > said, Hey, how about this? 40 - > And it was just kind of fortuitous that uh, you know, it 41 - > caused me to have to think about, okay, well, what do you 42 - > want to do in the last innings here, your your career? 43 - > Um, and uh, you know, kind of forced me to think about what 44 - > what that guiding light was, what that true north was.
45 - > And uh I just I picked three companies to work with uh in 46 - > areas that I thought would be uh thought would be interesting for 47 - > me. 48 - > Well, what is that true north? 49 - > Well, the true north's helping advance healthcare supply chain. 50 - > Um so that that's the overriding uh piece of it.
51 - > Um and you know, out of the gate, I'm really doing it in 52 - > three ways. 53 - > Uh one is is through AI and technology adoption. 54 - > Uh and in that realm, I'm supporting uh a company called 55 - > Clarion. 56 - > Uh, it's an AI uh platform company.
57 - > Uh I'm working on indirect spend, right? 58 - > I watched uh the areas of supply chain, 40% of the total cost of 59 - > supply chain if the health system is related to products 60 - > that don't come and of services that don't come in a box. 61 - > Um, you know, 800 different categories of them. 62 - > I watched it, wrote research around it, and uh it just hadn't 63 - > made a lot of progress.
64 - > So in that capacity, I'm an advisor for uh a new company to 65 - > the industry called Logic Source. 66 - > They've been around in other industries with great success uh 67 - > and are bringing that model to healthcare. 68 - > It's been uh it's been a great service so far. 69 - > Uh and then lastly, I work with Visiant on metrics and 70 - > benchmarking.
71 - > Uh so uh the work that they have uh kind of looked at that and 72 - > said, I'd done a lot of work around how systems think about 73 - > their maturity and uh and and how they measure that, both 74 - > quantitatively and quantit quantitatively, qualitatively 75 - > and quantitatively, uh, and trying to use uh kind of 76 - > determine that had a company that had data in an ecosystem uh 77 - > was another interesting way to look at it uh to get you know a 78 - > more definitive comparison of of what that looks like.
79 - > So I'm trying to help Vizn around that for their uh for 80 - > their membership. 81 - > So you know, kind of maturity, AI and technology, and then you 82 - > know, these areas of underdeveloped spend. 83 - > And uh I may at some point add to capital equipment. 84 - > It's another area that I find pretty interesting.
85 - > Uh it's a much bigger part of supply chain than most people 86 - > think, uh, about 7% of the total spend uh and it gets 87 - > underrepresented. 88 - > So I don't do anything there specifically, but uh I've got 89 - > interest. 90 - > SPEAKER_03: Well, you know, I I think uh when you talk about 91 - > capital, you're sort of getting into another thing that I see, 92 - > and that is as as IDNs uh grow and become uh continue to 93 - > acquire and merge with other uh hospitals or systems, uh they're 94 - > acquiring uh places that needed help or they probably wouldn't 95 - > have failed to the point where they had to merge.
96 - > Is that fair to say? 97 - > And then if that is fair to say, then there's a whole area that 98 - > they have probably ignored or done poorly, and that is capital 99 - > equipment planning and and and uh and standardization and and 100 - > the philosophy of of how to maintain that capital equipment. 101 - > I was at ARM a couple years ago and uh I was at a presentation 102 - > by an Air Force colonel, and there were a whole bunch of 103 - > senior officers in the in the background.
104 - > And when we got done, I asked one of the Air Force colonels, I 105 - > said, you know, how come the defense budget is shot up to the 106 - > point where it's nine hundred and seventy billion dollars now? 107 - > And he says because of the cost of uh of capital equipment, 108 - > because of the cost of capital and uh weapons, and and uh he 109 - > said it's not the people, it's the stuff. 110 - > And I think if that's true there, it's also true in 111 - > healthcare. 112 - > But let's get into your three areas.
113 - > Um talk about this. 114 - > I noticed you had written to me about doubling investment in 115 - > technology, uh AI and analytics. 116 - > Uh, how would you go about doubling investment in 117 - > technology? 118 - > Where would you focus your efforts?
119 - > And just give us a little bit of your insights on that area. 120 - > SPEAKER_02: Yeah. 121 - > In some of the benchmarking work uh, you know, that I'd done in 122 - > the past, uh, we don't cover that, you know, this area just 123 - > wasn't uh it was a small portion of the operating budget of 124 - > supply chain. 125 - > Um, you know, and so I looked at it and a lot of it was tied to 126 - > ERP investments, and then some of these kind of just I call 127 - > them kind of episodic platforms that the that organizations had 128 - > bought over the years.
129 - > And this is at the health system level. 130 - > Um and uh so I I just I think as you kind of come through this, 131 - > we've invested a lot in you know, kind of capital assets and 132 - > a lot of stuff around logistics and the movement of products, 133 - > specifically MedSurge. 134 - > And I just think we need to shift some of this budget to 135 - > thinking about how we get to these AI platforms that start to 136 - > tie the data together on multiple different efforts and 137 - > leverage and take out costs of uh employees through the use of 138 - > agents uh and use that data in a different way to uh aid and 139 - > assist in standardization, uh, ways to think about inventory 140 - > and risk and resiliency.
141 - > So there's all these different kinds of roadmaps that these 142 - > these companies uh that are building out these platforms 143 - > have, um, and and health systems for whatever reason, I think 144 - > some of it's just that they haven't been able to get 145 - > investment in many cases, or at least the middle of our market 146 - > hasn't been able to do that, should be leaning into these 147 - > technologies, uh voting with their dollars to support them, 148 - > uh picking a platform company that's got a roadmap that aligns 149 - > to what they're doing, um, you know, and and then expect, uh, 150 - > much like you'd buy a CSC and use that as a city on a hill to 151 - > drive compliance and understanding a supply chain, 152 - > these data and technology and AI investments to leverage and 153 - > bring the value from the 40% of the health system budget that's 154 - > tied to supply chain should just be something that that health 155 - > systems are leaning into.
156 - > And for whatever reason, um, you know, we've we've we've looked 157 - > at some of these vendors over the years as at kind of an arm's 158 - > length, many, many have. 159 - > Um, and I think it's time to do what other industries have done, 160 - > which is embrace them, uh, bring them into the fold, invest in 161 - > them, uh, expect a lot out of them when you're doing it, but 162 - > uh but uh but lean in a little bit more than we've done. 163 - > SPEAKER_03: You know, you have a you have sort of a wide global 164 - > view of of healthcare.
165 - > So your your experience spans you know uh a great gamut. 166 - > Uh is there anyone that is approaching the use of 167 - > technology and AI? 168 - > And I don't say just AI, technology and AI uh well that 169 - > you've seen that you could tell us about. 170 - > And uh what what areas of operations, either in supply 171 - > chain or in just the healthcare uh organization itself, would 172 - > you sort of earmark as places to start uh with the use of AI?
173 - > SPEAKER_02: Yeah, I mean there's I view it as a haves and have 174 - > nots. 175 - > Uh and you know, you can you can look to some of the more mature 176 - > health systems uh in my old world at Gartner, uh the Mayo 177 - > Clinics, the Cleveland Clinics, uh Intermountain, um, Stanford, 178 - > uh, Advent Health. 179 - > I mean, some of these organizations have really 180 - > invested in this and seen it as some of their um, you know, kind 181 - > of core operations of their business.
182 - > And there's more uh, you know, that have have done that as 183 - > well. 184 - > But uh, you know, those are good places to look and go, hey, how 185 - > are they bringing these 30 to 60 different areas that have data 186 - > for supply chain somehow touching it and bringing it to 187 - > the market? 188 - > Um, you know, and to me it's not it's not that hard. 189 - > There's a risk and resiliency piece of this, a service piece 190 - > that are being built out.
191 - > Uh, there's the ability to take uh, you know, and and use AI and 192 - > the transaction to make sure that you're getting the right 193 - > price, um, you know, in the in perfect order, um, you know, and 194 - > and make sure you're capturing all the value in the financial 195 - > transaction. 196 - > Um there's a lot of work uh that is being done that's really uh 197 - > effective and cool in preference card clinical areas uh and the 198 - > way that those are being managed and standardized in in a way 199 - > that uh that brings new value.
200 - > Um, you know, and then there's there's leverage across other 201 - > applications as well uh that sit in contract lifecycle 202 - > management. 203 - > Uh there's ways to use AI in the way that indirect spend is being 204 - > managed. 205 - > Um and so I think what you have to do is find those companies 206 - > that are really employing it and not just words, word giving 207 - > words to it, but showing and demonstrating resources that are 208 - > out there. 209 - > And uh, you know, it it lends you to some of these companies 210 - > that are, I mean, we don't have a lot of venture-backed 211 - > organizations that are coming into the healthcare supply 212 - > chain, but there are some uh that are that are out there that 213 - > are bringing real dollars, real investment into the uh industry, 214 - > and you know, we should be finding a way to support those.
215 - > And um, you know, if the incumbents are uh investing in 216 - > those areas, we should be leaning into the solutions that 217 - > they're bringing too. 218 - > SPEAKER_03: Are there are there companies that uh you know the 219 - > the the rapid rise in technology is so recent? 220 - > Are there uh companies out there that can show demonstrated ROIs 221 - > for their for their uh offerings? 222 - > The measured ROIs that they actually have produced results, 223 - > or is it still all a narrative under part?
224 - > SPEAKER_02: No, there's companies that are that are 225 - > doing it. 226 - > Um, you know, some of them, uh, you know, you've got to you've 227 - > got to attribute some um you know soft dollars of value to it 228 - > uh in a in a little bit. 229 - > You know, what's the value of resiliency uh, you know, and a 230 - > predictable supply chain is tougher. 231 - > Some of the stuff that's around preference card management uh in 232 - > the OR and some of the transactional pieces uh that go, 233 - > hey, are we are we paying the same price?
234 - > Uh are we are we rationalizing uh you know and making sure 235 - > we're taking advantage of all our terms systematically? 236 - > Uh are we thinking about our spend and categorizing it in the 237 - > right way? 238 - > Some of those areas are showing some pretty clear ROI. 239 - > Um, you know, but as you mentioned, we're early, right?
240 - > This is, I don't know, inning two uh of a nine-inning game. 241 - > Um and so it's some of this is an evolving practice where 242 - > leaders are are layering into these technologies and learning 243 - > from each other. 244 - > Um, and so it's almost like a sandbox in a way that go, hey, 245 - > let's learn from each other. 246 - > We're developing you know these solutions for um, you know, 247 - > other health systems that uh that we may not be competitive 248 - > with, and how do we learn from each other?
249 - > Um, you know, but you've got to at the end of it have investment 250 - > in those resources to go after it. 251 - > And uh, you know, those are some of the companies that I'm trying 252 - > to lean into where they've got those resources, they've got 253 - > that platform, um, you know, and they're and they're coming at it 254 - > from a a different angle, uh, you know, with that investment 255 - > in uh in tow. 256 - > SPEAKER_03: And and then you have the uh systems.
257 - > Are the systems eager to incorporate technology or are 258 - > they desperate to incorporate technology? 259 - > SPEAKER_02: Uh I'd say eager would be better. 260 - > Uh many of them just don't quite know, you know, kind of where to 261 - > go, or they may pick a a place. 262 - > Uh, you know, they may be under pressure to reduce their staff.
263 - > That's still a um, you know, a pretty pressing issue, um, uh 264 - > supply chain talent uh and staffing. 265 - > And so there's some folks that are very you know centered on 266 - > the agent model and how they reduce labor through this. 267 - > I I think the bigger opportunities on the data uh and 268 - > the way that you yield that data and tie those systems together 269 - > and use AI to make better decisions uh and and and enable 270 - > cost savings. 271 - > Um but I think most see it as an opportunity, it's kind of a 272 - > carrot.
273 - > But there's also many, because you you know you talked about 274 - > the ROI, um, where the ROI is is is out there, um, you know, they 275 - > they don't want to go implement 20 different solutions. 276 - > Um so it's what's led me to this kind of platform concept, which 277 - > is hey, pick a platform, uh, and there's there's multiple out 278 - > there uh that's got a roadmap that you believe in. 279 - > Um get your organization to buy into, because most most of the 280 - > health systems are saying, you know, they've got an AI strategy 281 - > uh for the for the whole business.
282 - > Um and how do you incorporate and layer in this supply chain 283 - > AI strategy that uh that that fits into that uh fits into that 284 - > mold. 285 - > So I think you've got to look at it as an opportunistic way to 286 - > yield benefits from multiple things without having to 287 - > implement you know six different partners uh or 10 different 288 - > partners or 12 different. 289 - > So I kind of view it's not necessarily best in class spot 290 - > solution. 291 - > It is platform with an expectation that you're gonna go 292 - > down the roadmap uh and spend more money and give more 293 - > resources to those companies that are that are building out 294 - > solutions that'll help you in aggregate across multiple 295 - > different areas of your supply chain.
296 - > SPEAKER_03: It's gonna take a lot of uh collaboration. 297 - > It's not just buy a box, plug it in, and uh see immediate uh 298 - > measurable savings. 299 - > You're gonna have to you're gonna have to work back and 300 - > forth with uh the supplier of this of this technology. 301 - > Is that fair to say?
302 - > SPEAKER_02: Yeah. 303 - > I mean, uh particularly in these early days. 304 - > Um, you know, and I guess those are always the questions, right? 305 - > Are you an early adopter, are you a late adopter?
306 - > Um, you know, my my take is it's better for most folks to be an 307 - > early adopter um, you know, and and and be part of the solution 308 - > and and building it out, right? 309 - > It's a collaborative industry that's got a lot of good things 310 - > going for it. 311 - > Um, you know, because if you wait for it to all be built out 312 - > in a perfect, you know, hey, just go do this and implement 313 - > it. 314 - > It's five years and you know, you're behind the uh you know, 315 - > you're behind the curve of of value compared to your peers.
316 - > And you know, everything that we know from the financial pressure 317 - > side says the next couple of years are gonna look a little 318 - > rougher uh just because of the reimbursement and the big, 319 - > beautiful bill and all the things that are are coming. 320 - > We'll see what actually comes from it. 321 - > But uh, you know, uh healthcare futurists that uh that I listen 322 - > to are saying, hey, this is this is gonna come to roost. 323 - > And um, you know, those that are preparing and thinking about it, 324 - > I think are gonna be ahead of it.
325 - > Um and my my strategy always for the chief supply chain officers 326 - > is you're the CEO of supply chain, uh, you know, you gotta 327 - > be thinking about the investments that you need to 328 - > deliver it. 329 - > You're not necessarily an operator, you're somebody 330 - > bringing resources to a problem to deliver value. 331 - > Um, and you know, AI, technology platforms, partners in a 332 - > different way across different areas of spend that maybe you 333 - > you don't have the capability or you haven't always been great 334 - > at.
335 - > It's time to, it's time to get more aggressive on the 336 - > partnering front than uh than maybe we've been in the in the 337 - > past. 338 - > Uh and there's some men that are just leaning into it uh and they 339 - > are leading the way and they're way ahead of me and kind of 340 - > where I think. 341 - > Uh, but there's a lot in kind of the middle that are that are a 342 - > little paralyzed. 343 - > And um, you know, I don't know how how to uh how to best help 344 - > those folks because in many cases they don't have senior 345 - > leadership that wakes up every morning understanding the value 346 - > that supply chain can deliver, not only on the cost front, but 347 - > on the whole alignment and integration into the fabric of 348 - > of delivering care.
349 - > So we still have work to do there. 350 - > SPEAKER_01: Before we dive back in, you may be asking yourself, 351 - > is my supply chain future ready? 352 - > CNOT Company, we don't just optimize logistics. 353 - > We engineer smarter, leaner, and more resilient systems from end 354 - > to end, from manufacturing to retail to healthcare.
355 - > Our experts bring decades of experience in cutting-edge 356 - > strategies to transform your operations. 357 - > Visit and discover how we're shaping the future of supply 358 - > chain one solution at a time. 359 - > SPEAKER_03: Okay, Eric, so we just finished talking about 360 - > technology, and I would argue that technology's opportunities 361 - > uh are new and increasing rapidly because of AI and and 362 - > machine learning and all the other tools that are developing.
363 - > But the other two areas that you talk about addressing, which is 364 - > the uh indirect spend and capital equipment, sort of fall 365 - > under the category, in my mind's eye, of it's about time. 366 - > These opportunities have been around forever. 367 - > They've been overlooked either because no one thought about 368 - > looking at them or it was too difficult. 369 - > Uh directors of areas where those opportunities exist would 370 - > be very protective of their uh of their departments and not 371 - > want any help or any input.
372 - > Uh and so uh we just kept trying to find better prices and get 373 - > rid of people. 374 - > So tell it tell us uh what you're doing in indirect 375 - > indirect spend and also after that into the areas of capital 376 - > equipment. 377 - > SPEAKER_02: Yeah, so indirect spend has just been one Fred, 378 - > and you you hit the nail on the head, right? 379 - > It's just been it's been out there for a long time.
380 - > Uh I've written different pieces of research around it over the 381 - > years uh around how to attack purchase services, the products 382 - > that don't, the services that don't come in a box, uh right? 383 - > They're they're highly variable in um you know the service 384 - > capabilities locally for these health systems, uh, and they 385 - > don't kind of uh align super well to national contracting. 386 - > Um, you know, and then it's super amorphous, 800 different 387 - > categories.
388 - > Uh and it's rare for health systems to kind of I don't know, 389 - > level set uh the way that they approach that for the dollars 390 - > that are spent in these areas uh with sourcing resources uh and 391 - > the capabilities to listen to end users, set a specification 392 - > for a service, uh, source it, and then hold the organization 393 - > accountable. 394 - > Um so, you know, I'm a I'm an advisor for Logic Source. 395 - > Um, you know, they're a new approach to going after this 396 - > spend.
397 - > Uh, and I've just kind of watched, you know, different 398 - > consulting firms, the GPOs, some of these technology platform 399 - > firms uh that have had promise, uh, but just still, for whatever 400 - > reason, we haven't quite nailed it down. 401 - > And uh I guess I'd attribute some of it to governments, uh, 402 - > just the right to come in and you know get access to the 403 - > spend, marketing spend, benefits spend, uh legal spend, uh 404 - > facilities spend, right?
405 - > These big categories uh of dollars uh that are equal or 406 - > greater to uh what's spent in medical surgical, medical 407 - > device, and even pharmaceuticals uh you know, uh kind of 408 - > combined. 409 - > It's about equal in what's spent in these services, uh, and we've 410 - > just under-resourced for it. 411 - > So I think there's got to be a different approach, and uh, and 412 - > that's the one that I'm trying to support with Logic Source to 413 - > come in and bring outside industry uh benchmarks uh and an 414 - > approach uh using technology to uh uh and uh and resources to uh 415 - > to to attack and address that spend.
416 - > SPEAKER_03: Well, I know Logic Source has got some high-level 417 - > uh people there with some real expertise. 418 - > My question is, how do you knock on the door of an organization 419 - > and get them to crack it open and give you the opportunity to 420 - > uh to you know to talk about what you might be able to do? 421 - > SPEAKER_02: Yeah, and I'm not on the sales side. 422 - > I'm on the advisory side and uh on the, I don't know, advocating 423 - > for a solution side.
424 - > Uh but but I do think as I've watched it, it it usually comes 425 - > uh in the best case, it's led by a chief supply chain officer 426 - > that goes, look, we haven't we haven't been able to address 427 - > this uh effectively. 428 - > Uh we need more resources, uh, and it's a catalyst bringing 429 - > somebody in like Logic Source to get those resources, to approach 430 - > these areas of spend and kind of get governance. 431 - > It's the city on a hill. 432 - > I I I I liken it to the equivalent of having a CSC.
433 - > Uh CSC uh you know for medical, surgical, and devices doesn't 434 - > necessarily uh mean you're gonna be the most mature health 435 - > system, but the health system understands it across the 436 - > enterprise when you've got the big building. 437 - > Uh so making an investment with a third party uh tends to, you 438 - > know, kind of make everybody go, yep, okay, we're supporting 439 - > this. 440 - > This is an initiative that we're going to. 441 - > But ultimately, typically the CFO, COO has to buy in and say, 442 - > yep, hey, this is an area we're going to invest in uh in a 443 - > different way and and go approach it.
444 - > Um, because you've got to get governance, there's got to be 445 - > somebody that's got air cover to go, hey, these departments that 446 - > have, as you mentioned, uh have historically kind of done their 447 - > own thing, uh, been Maverick spenders. 448 - > Um, you know, we've we've Got to kind of align that under a 449 - > professional supply chain service, and uh you know, we we 450 - > can yield a benefit from it. 451 - > And the benefit's been great, uh, but you've got to have 452 - > governance uh to go after it first.
453 - > It's the it's the uh you know, get uh get helicopters in the 454 - > jail, uh in the jailbreak uh initiative. 455 - > Somebody's gotta, you know, uh has the has the tough one that 456 - > they've got to capture. 457 - > SPEAKER_03: Yeah, well, you know, with the given the fiscal 458 - > challenges that everybody faces, uh I think mo all organizations 459 - > are more willing to approach these opportunities. 460 - > And that brings us to the last one, the cap capital equipment 461 - > planning.
462 - > I've w remember the 60 years I've been in healthcare, every 463 - > year it used to be a free-for-all for the capital 464 - > budget. 465 - > And that was when most places were standalone community 466 - > hospitals. 467 - > Now you have systems with uh 10, 12, 15, 20 hospitals plus uh uh 468 - > scores of other delivery areas and you have to capitalize those 469 - > places and you have to come up with a plan. 470 - > Um how do you go about addressing that?
471 - > What what would you uh tell us tell us about the approach that 472 - > people should be looking at for managing and handling those 473 - > those uh things? 474 - > SPEAKER_02: Well, I think first it's a recognition of just what 475 - > how much of the spend it represents. 476 - > And it's not quite the equivalent of MedSurge in terms 477 - > of dollars, but it's 70% of it. 478 - > Uh you know, it's big if you think about rolling capital and 479 - > the hundreds of categories of of those uh products that are out 480 - > there, um, you know, and the fact uh that many of them have 481 - > also a utilization component of it, whereas you've bought them, 482 - > uh you've got to standardize it on it, and then you've got those 483 - > assets in different locations, and they may not be utilized uh 484 - > as efficiently as they could be.
485 - > So it's really it's it I guess it's really just a resource 486 - > allocation process and a governance process that says, 487 - > yes, supply chain should own this, yes, there's a budgeting 488 - > component of it, yes, there's a standardization across these 489 - > growing health systems that have got you know more locations, uh, 490 - > you know, and then there's an uptime uh and a life cycle to 491 - > this equipment. 492 - > So today we see it managed still predominantly on spreadsheets, 493 - > uh, you know, and sometimes with a clinical engineering 494 - > biomedical company that comes along as a partner, uh, but 495 - > still it's not necessarily tied directly to the budgeting, uh, 496 - > it's not tied directly to new construction uh and the and the 497 - > addition of facilities.
498 - > And for sure, it's not always, particularly with the MA 499 - > activity, you know, standardized across the enterprise. 500 - > So really putting resources toward it would be my first 501 - > thing, an owner uh of capital equipment as you know, seven to 502 - > ten percent of the total spend of supply chain, um, enabling 503 - > that with technology platform, uh, you know, and a partner on 504 - > the uh biomedical clinical engineering side uh that just 505 - > looks at you know everything from budgeting uh and and offer 506 - > uh to sourcing uh to product lifecycle management to 507 - > end-of-life uh process, uh, you know, to kind of uptime and 508 - > allocation of the uh of the equipment.
509 - > It's a real opportunity. 510 - > Uh, and it's also got a cybersecurity component of it. 511 - > We're watching in some cases this getting now pushed to the 512 - > the to the chief technology officer uh on the side in terms 513 - > of ownership because of um you know the cybersecurity issues 514 - > that that uh that that are exposed here. 515 - > So I think it's really a comprehensive look at the total 516 - > expense, uh the risk of the organization, uh, and just you 517 - > know how you how you best have uh that equipment in the right 518 - > place for clinicians to do their job uh efficiently and 519 - > effectively.
520 - > Uh there's partnership opportunities with the 521 - > manufacturers, there's partnership opportunities with 522 - > the biomedical companies, and there's really some growing 523 - > great technology platform companies that are the 524 - > foundation of this that uh I just think are under 525 - > underinvested in. 526 - > SPEAKER_03: Yeah, and the one commonality among all three of 527 - > the areas that you've you're focusing on uh is you have to 528 - > have strong leadership, you have to have visionary leadership, 529 - > you have to have capable leadership uh at at uh the uh at 530 - > all levels from uh from an administrative level, excuse me, 531 - > to uh to uh um contracting level to to whatever.
532 - > And uh so you got you gotta want to do it. 533 - > If you want to bring process into uh an organization, you 534 - > gotta be willing to commit to providing the correct the right 535 - > resources and the support to get it done. 536 - > Is that fair? 537 - > SPEAKER_02: It is.
538 - > And it, you know, as you point out, right? 539 - > It's a little bit like non-acute. 540 - > When we when when these health systems bought all the physician 541 - > offices, uh a lot of health systems went down the path and 542 - > said, Hey, I'm gonna take a really good uh up-and-coming 543 - > person in my organization and put them in charge of non-acute. 544 - > Uh, it's the same thing for, it should be the same thing for 545 - > capital, and it should be the same thing for indirect spend.
546 - > They're huge categories. 547 - > Uh, they deserve a leader that uh has a career path within it 548 - > uh that can uh that can grow it. 549 - > You know, the number of health systems that I talk to that are 550 - > you know three to five billion dollars that have a couple 551 - > people kind of randomly doing capital equipment and uh you 552 - > know, three or four that might be doing purchase services, 553 - > indirect spend, uh they're just really under-resourced, both 554 - > from a personnel standpoint.
555 - > And then if you hire the right leaders, that leader is gonna 556 - > say, is effectively gonna go, look, I can't do my job without 557 - > partners, without technology. 558 - > So it kind of rolls down, I think, like many things from 559 - > that leadership. 560 - > And uh, but you've got to get resources to it, uh, and we've 561 - > just under-resourced it. 562 - > SPEAKER_03: Yeah, historically that's been uh that's been a uh 563 - > symptom or uh of healthcare in general, supply chain in 564 - > particular, under-resource.
565 - > Well, Eric, excuse me. 566 - > Um thanks for joining us. 567 - > And there are two areas that we've left out that I'd like to 568 - > have a future discussion about. 569 - > Number one is the emerging supply chain leader, what what 570 - > that person needs to look like, what that person's capabilities 571 - > need to be, um what you see out there, uh who you've seen has 572 - > done things well, what you would advocate.
573 - > And and uh the second part is is what I casually call 574 - > benchmarking, but but measuring your operation to the point 575 - > where you can measure yourself so that you can see how 576 - > effective things that you've tried to implement are toward 577 - > improvements. 578 - > And this is where your expertise has been in in benchmarking, and 579 - > and I think that uh a lot of people would love to hear your 580 - > insights on that. 581 - > So would it be possible to get you back for another uh episode 582 - > sometime in the near future?
583 - > SPEAKER_02: You bet, Fred. 584 - > Uh, you know, you're a bright light. 585 - > I love I love your voice in the industry and uh appreciate you 586 - > having me on today. 587 - > And I'd love to talk about both those issues.
588 - > They're meaty and uh uh lots of things that are going on that 589 - > are great, uh, but also you know, areas for for development 590 - > as well. 591 - > SPEAKER_03: Okay, well, Eric, thank you so much for joining 592 - > us. 593 - > And I I appreciate, I know that we've had a couple stumbles here 594 - > with technology ourselves as we've been trying to do this 595 - > podcast, and I appreciate you for hanging in there and uh hope 596 - > to talk to you again soon in the future.
597 - > SPEAKER_02: Thanks, Fred. 598 - > Be good. 599 - > SPEAKER_03: Take care. 600 - > SPEAKER_01: Well, that's all for today.
601 - > Thanks so much for joining us. 602 - > And don't forget to hit that subscribe button and connect 603 - > with us online so you'll never miss an episode and can catch up 604 - > on all the ones you might have missed. 605 - > Got a topic you're fired up about, or maybe you want to be a 606 - > guest on the show? 607 - > Fred would love to hear from you.
608 - > Just reach out at f c r n s at s tonge.com. 609 - > We'll see you next time.
Other episodes covering the same guests and topics, from across The B2B Podcast Index.